Conferences

ecancer travels so that you don't have to. Explore the latest conference coverage in global oncology and find out where we are going next.
Bookmark and Share

19th Congress of the European Hematology Association (EHA 19)

12 - 15 Jun 2014
MiCo, Milan, Italy
Thrombosis in adult patients with chronic ITP
Dr Howard Liebman - University of Southern California, Los Angeles, USA
Thrombosis in adult patients with chronic ITP ( Dr Howard Liebman - University of Southern California, Los Angeles, USA )
4 Sep 2014
Hot topic: B-cell depletion in adult chronic ITP
Dr Francesco Zaja - University of Udine, Udine, Italy
Hot topic: B-cell depletion in adult chronic ITP ( Dr Francesco Zaja - University of Udine, Udine, Italy )
4 Sep 2014
Treatment options in adult chronic idiopathic thrombocytopenic purpura: Introduc...
Prof Aristoteles Giagounidis - St John’s Hospital, Duisburg, Germany
Treatment options in adult chronic idiopathic thrombocytopenic purpura: Introduction ( Prof Aristoteles Giagounidis - St John’s Hospital, Duisburg, Germany )
4 Sep 2014
How do TPO-R agonists impact the daily lives of chronic ITP patients? Lessons fr...
Prof Aristoteles Giagounidis - St. John’s Hospital, Duisburg, Germany
How do TPO-R agonists impact the daily lives of chronic ITP patients? Lessons from long-term studies ( Prof Aristoteles Giagounidis - St. John’s Hospital, Duisburg, Germany )
4 Sep 2014
Prolonged response to TPO-R agonists
Dr James Bussel - Cornell University, Ithaca, USA
Prolonged response to TPO-R agonists ( Dr James Bussel - Cornell University, Ithaca, USA )
4 Sep 2014
Effects of one TPO-R agonist after discontinuing another?
Prof Aristoteles Giagounidis - St. John’s Hospital, Duisburg, Germany
Effects of one TPO-R agonist after discontinuing another? ( Prof Aristoteles Giagounidis - St. John’s Hospital, Duisburg, Germany )
4 Sep 2014
Treatment options in adult chronic idiopathic thrombocytopenic purpura: Panel di...
Prof Aristoteles Giagounidis; Dr Francesco Zaja; Dr James Bussel; Dr Howard Lieb...
Treatment options in adult chronic idiopathic thrombocytopenic purpura: Panel discussion ( Prof Aristoteles Giagounidis; Dr Francesco Zaja; Dr James Bussel; Dr Howard Liebman )
13 Aug 2014
Tackling inequality in access to cancer care and information
Prof Mark Lawler - Queen's University Belfast, Belfast, UK
Tackling inequality in access to cancer care and information ( Prof Mark Lawler - Queen's University Belfast, Belfast, UK )
20 Jun 2014
Retinoic acid in acute promyelocytic leukaemia as alternative to chemotherapy
Dr Luca Mazzarella - European Institute of Oncology, Milan, Italy
Retinoic acid in acute promyelocytic leukaemia as alternative to chemotherapy ( Dr Luca Mazzarella - European Institute of Oncology, Milan, Italy )
20 Jun 2014
Relationship between metabolism and cancer growth in acute promyelocytic leukaem...
Dr Luca Mazzarella - European Institute of Oncology, Milan, Italy
Relationship between metabolism and cancer growth in acute promyelocytic leukaemia ( Dr Luca Mazzarella - European Institute of Oncology, Milan, Italy )
20 Jun 2014
Gdf -11 a new target to improve anaemia in thalassemia
Prof Olivier Hermine - Université Paris Descartes, Paris, France
Gdf -11 a new target to improve anaemia in thalassemia ( Prof Olivier Hermine - Université Paris Descartes, Paris, France )
20 Jun 2014
Advances in multiple myeloma: Expert discussion
Prof Sonja Zweegman and Prof Matti Aapro
Advances in multiple myeloma: Expert discussion ( Prof Sonja Zweegman and Prof Matti Aapro )
20 Jun 2014
Biomarkers in CLL prognosis
Prof Robin Foà - Sapienza University of Rome, Rome, Italy
Biomarkers in CLL prognosis ( Prof Robin Foà - Sapienza University of Rome, Rome, Italy )
20 Jun 2014
Philadelphia chromosome and the role it plays in chronic myeloid leukaemia
Prof Christine Harrison - Newcastle University, Newcastle, UK
Philadelphia chromosome and the role it plays in chronic myeloid leukaemia ( Prof Christine Harrison - Newcastle University, Newcastle, UK )
20 Jun 2014
Eltrombopag helped reduce bleeding in children with immune thrombocytopenic purp...
Dr John Grainger - Royal Manchester Children's Hospital, Manchester, UK
Eltrombopag helped reduce bleeding in children with immune thrombocytopenic purpura ( Dr John Grainger - Royal Manchester Children's Hospital, Manchester, UK )
20 Jun 2014
Pivotal ruxolitinib data shows promise for patients with PV
Prof Alessandro Vannucchi - University of Florence, Florence, Italy
Pivotal ruxolitinib data shows promise for patients with PV ( Prof Alessandro Vannucchi - University of Florence, Florence, Italy )
20 Jun 2014
Multiple myeloma in the elderly: Expert discussion
Prof Philippe Moreau and Prof Marivi Mateos
Multiple myeloma in the elderly: Expert discussion ( Prof Philippe Moreau and Prof Marivi Mateos )
20 Jun 2014
Novel targeting in acute myeloid leukaemia
Prof Giovanni Martinelli - University of Bologna, Bologna, Italy
Novel targeting in acute myeloid leukaemia ( Prof Giovanni Martinelli - University of Bologna, Bologna, Italy )
20 Jun 2014
Personalised medicine in Europe needs to be accessible to all
Prof Mark Lawler - Queen's University Belfast, Belfast, UK
Personalised medicine in Europe needs to be accessible to all ( Prof Mark Lawler - Queen's University Belfast, Belfast, UK )
20 Jun 2014
Treatment of acute lymphoblastic leukaemia by activation of patient's immune cel...
Dr Nicola Gökbuget - Goethe University Frankfurt, Frankfurt, Germany
Treatment of acute lymphoblastic leukaemia by activation of patient's immune cells by a bispecific antibody ( Dr Nicola Gökbuget - Goethe University Frankfurt, Frankfurt, Germany )
20 Jun 2014
Better understandings of gene mutations aid diagnostic tools in CLL
Dr Elías Campo - University of Barcelona, Barcelona, Spain
Better understandings of gene mutations aid diagnostic tools in CLL ( Dr Elías Campo - University of Barcelona, Barcelona, Spain )
19 Jun 2014
Eltrombopag helped reduce bleeding in children with immune thrombocytopenic purp...
Dr John Grainger - Royal Manchester Children's Hospital, Manchester, UK
Eltrombopag helped reduce bleeding in children with immune thrombocytopenic purpura ( Dr John Grainger - Royal Manchester Children's Hospital, Manchester, UK )
19 Jun 2014
Novel Bcl-2 specific inhibitor updated results confirm substantial activity and ...
Dr John Seymour - Peter MacCallum Cancer Centre, Melbourne, Australia
Novel Bcl-2 specific inhibitor updated results confirm substantial activity and durable responses in high-risk CLL ( Dr John Seymour - Peter MacCallum Cancer Centre, Melbourne, Australia )
19 Jun 2014
Lenalidomide versus thalidomide in myeloma
Prof Keith Stewart - Mayo Clinic, Scottsdale, USA
Lenalidomide versus thalidomide in myeloma ( Prof Keith Stewart - Mayo Clinic, Scottsdale, USA )
19 Jun 2014
Comment: Advances in haematological cancer presented at EHA 2014
Prof Pieter Sonneveld - University Hospital Rotterdam, Netherlands
Comment: Advances in haematological cancer presented at EHA 2014 ( Prof Pieter Sonneveld - University Hospital Rotterdam, Netherlands )
19 Jun 2014
Advances in mantle cell lymphoma: Expert discussion
Prof Simon Rule and Prof Franco Cavalli
Advances in mantle cell lymphoma: Expert discussion ( Prof Simon Rule and Prof Franco Cavalli )
19 Jun 2014
Advances in chronic lymphocytic leukaemia: Expert panel discussion
Prof Peter Hillmen; Prof John Gribben; Prof Stephen Mulligan
Advances in chronic lymphocytic leukaemia: Expert panel discussion ( Prof Peter Hillmen; Prof John Gribben; Prof Stephen Mulligan )
19 Jun 2014
Genetically modified T cells fight haematological cancer
Dr Roman Galetto - Cellectis Therapeutics, Paris, France
Genetically modified T cells fight haematological cancer ( Dr Roman Galetto - Cellectis Therapeutics, Paris, France )
19 Jun 2014
Pivotal ruxolitinib data shows promise for patients with PV
Prof Alessandro Vannucchi - University of Florence, Florence, Italy
Pivotal ruxolitinib data shows promise for patients with PV ( Prof Alessandro Vannucchi - University of Florence, Florence, Italy )
19 Jun 2014
Novel Bcl-2 specific inhibitor updated results confirm substantial activity and ...
Dr John Seymour - Peter MacCallum Cancer Centre, Melbourne, Australia
Novel Bcl-2 specific inhibitor updated results confirm substantial activity and durable responses in high-risk CLL ( Dr John Seymour - Peter MacCallum Cancer Centre, Melbourne, Australia )
19 Jun 2014
Does the use of generics of imatinib for chronic myeloid leukaemia jeopardise pa...
Dr Zafer Başlar - Istanbul University, Istanbul, Turkey
Does the use of generics of imatinib for chronic myeloid leukaemia jeopardise patient safety? ( Dr Zafer Başlar - Istanbul University, Istanbul, Turkey )
19 Jun 2014
Ibrutinib improves survival in CLL and SLL patients, RESONATE study shows
Prof Peter Hillmen - St James’ University Hospital, Leeds, UK
Ibrutinib improves survival in CLL and SLL patients, RESONATE study shows ( Prof Peter Hillmen - St James’ University  Hospital, Leeds, UK )
19 Jun 2014